Expertise in
3
conditions

Pedro A. Kowacs

Curitiba PR, 
Curitiba, PR, BR 
Expertise in
3
conditions
Curitiba PR, 
Curitiba, PR, BR 

Overview

Pedro Kowacs practices practicing medicine in Curitiba, Brazil.

Mr. Kowacs is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Seizures, Migraine, Epilepsy, and Headache.

He is actively involved in clinical research, co-authoring 54 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Curitiba PR, Curitiba, PR, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: August 28, 2024
Intervention Type: Biological
Study Drug: HYQVIA
Study Phase: Phase 3
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological
Study Drugs: HYQVIA, Intravenous Immunoglobulin G
Study Phase: Phase 3
View 1 Less Clinical Trial

54 Total Publications

Sleep psychoeducation strategies for patients with chronic migraine and sleep quality complaints.
Sleep psychoeducation strategies for patients with chronic migraine and sleep quality complaints.
Journal: Arquivos de neuro-psiquiatria
Published: March 11, 2026

Frequently Asked Questions about Pedro A. Kowacs

Is Pedro A. Kowacs a top-rated expert for Seizures?

MediFind is an objective health platform that identifies experts based on real-world data. Pedro A. Kowacs is classified as an Advanced expert for Seizures, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pedro A. Kowacs participate in research or clinical trials?

Yes. Pedro A. Kowacs has published 54 articles and abstracts on conditions like Seizures. You can view a list of Pedro A. Kowacs's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kowacs's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile